About this trial
What is this study about? This research is focused on improving the care for people with rare heart muscle diseases, known as rare cardiomyopathies. These are uncommon conditions where the heart muscle becomes stiff, thick, or enlarged, making it harder for the heart to pump blood. Because they are rare, they can be difficult to diagnose and manage.
The investigators are testing new, advanced ways of using a heart scan called a Cardiac Magnetic Resonance (CMR). Participants can think of a CMR as a very powerful camera that takes detailed pictures of their heart without using radiation.
What is the study trying to learn? Better Diagnosis: The investigators want to see if these new scanning techniques can help us identify these rare heart conditions more clearly and accurately. This means patients could get a correct diagnosis sooner.
Personalized Risk Assessment: The investigators want to see if the scan can help us understand the future risk for each patient better. For example, can it help predict which patients are more likely to have a heart rhythm problem or need specific treatments? This helps doctors create a care plan that is tailored just for participants.
What does this mean for participants? If participants choose to take part, they will undergo a CMR scan that uses these new techniques. By participating, they will be helping us find better ways to diagnose and care for people with their condition in the future. The goal is to turn uncertainty into clearer, more personalized information for patients and families.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients who have received a cardiac magnetic resonance examination since 2010 and have a suspicion of rare cardiomyopathy.
Disqualifiers
Severe arrhythmia;
Severe primary cardiac valvular disease;
Refuse to participate in the study.
Trial population
Patients who have received a cardiac magnetic resonance examination since 2010 and have a suspicion of rare cardiomyopathy.
Trial design
Case-control
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Incidence Rate of All-cause Death
the incidence of all-cause death
Incidence Rate of Cardiovascular Death
the incidence of cadridovascular death
Incidence Rate of Heart Transplantation
Secondary outcomes
Incidence Rate of Hospitalization Due to Heart Failure
Incidence Rate of Implantable cardioverter-defibrillator Implantation
Incidence Rate of Pacemaker Implantation
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Chinese Academy of Medical Sciences, Fuwai Hospital
Lead sponsor
Peking Union Medical College Hospital
Collaborator
Beijing Anzhen Hospital
Collaborator
The First Affiliated Hospital with Nanjing Medical University
Collaborator